VNO
52
-9
DE
38
-4
AIV
62
-2
MU
38
-4
URI
70
-2
LEN
50
-6
MO
62
5
CMG
72
5
AXP
69
-2
CVX
32
-5
FOX
60
5
TSCO
51
-2
MRO
43
-3
CMS
58
-2
KHC
13
-4
SRE
69
-2
TEL
71
2
D
40
-5
GT
62
-3
GS
79
-4
VNO
52
-9
DE
38
-4
AIV
62
-2
MU
38
-4
URI
70
-2
LEN
50
-6
MO
62
5
CMG
72
5
AXP
69
-2
CVX
32
-5
FOX
60
5
TSCO
51
-2
MRO
43
-3
CMS
58
-2
KHC
13
-4
SRE
69
-2
TEL
71
2
D
40
-5
GT
62
-3
GS
79
-4
Financhill
Back

Citius Oncology Vs. Aritzia Industry Stock Comparison

Sell
1

CTOR
Citius Oncology

Last Price:
1.18
Seasonality Move:
--
Sell
40

ATZAF
Aritzia

Last Price:
33.13
Seasonality Move:
14.48%
Sell
1
Citius Oncology (CTOR) is a Sell

Is Citius Oncology a Buy, Sell or Hold?

  • The current Citius Oncology [CTOR] share price is $1.22. The Score for CTOR is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • CTOR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Aritzia (ATZAF) is a Sell

Is Aritzia a Buy, Sell or Hold?

  • The current Aritzia [ATZAF] share price is $33.13. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CTOR Stock Price Chart

What is Citius Oncology's stock price today?

  • The Citius Oncology share price today is $1.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTOR is experiencing selling pressure, which indicates risk of future bearish movement.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

  • The Aritzia share price today is $33.13
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATZAF is experiencing slight buying pressure.

CTOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 46.94 Sell
Chaikin Money Flow: -41402 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.07 - 1.27) Buy
Bollinger Bands (100): ( - ) Buy

ATZAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 51.58 Buy
Chaikin Money Flow: 485 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.46 - 34.6) Buy
Bollinger Bands (100): (30.22 - 35.52) Buy

CTOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.23 Sell
20-day SMA: 1.21 Buy
50-day SMA: 1.34 Sell
200-day SMA: 0 Buy
8-day EMA: 1.24 Sell
20-day EMA: 1.23 Sell
50-day EMA: 1.41 Sell
200-day EMA: 0.1 Buy

ATZAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.85 Buy
20-day SMA: 31.82 Buy
50-day SMA: 34.06 Sell
200-day SMA: 29.54 Buy
8-day EMA: 31.74 Buy
20-day EMA: 32.3 Buy
50-day EMA: 33.02 Buy
200-day EMA: 30 Buy

Citius Oncology Earnings Growth & CTOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aritzia Earnings Growth & ATZAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.

Citius Oncology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aritzia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):